Pfizer SG&A Expense (Annual) Trends

Pfizer Inc (PFE)

28.64 -0.28 (-0.97%) USD | NYSE | May 17, 16:00

28.72 +0.08 (+0.28%) Pre-Market: 20:00

SG&A Expense (Annual) Chart

Historical SG&A Expense (Annual) Data

View and export this data back to 1984. Upgrade now.

Date	Value
December 31, 2023	14.77B
December 31, 2022	13.68B
December 31, 2021	12.70B
December 31, 2020	11.60B
December 31, 2019	12.73B
December 31, 2018	12.61B
December 31, 2017	14.80B
December 31, 2016	14.84B
December 31, 2015	14.81B
December 31, 2014	14.10B
December 31, 2013	14.36B
December 31, 2012	15.17B
December 31, 2011	17.58B
December 31, 2010	18.97B
December 31, 2009	14.88B
December 31, 2008	14.54B
December 31, 2007	15.63B
December 31, 2006	15.59B
December 31, 2005	15.31B
December 31, 2004	15.30B

Date	Value
December 31, 2003	15.11B
December 31, 2002	10.83B
December 31, 2001	9.717B
December 31, 2000	11.22B
December 31, 1999	10.81B
December 31, 1998	9.563B
December 31, 1997	4.401B
December 31, 1996	3.859B
December 31, 1995	5.297B
December 31, 1994	4.390B
December 31, 1993	4.792B
December 31, 1992	3.762B
December 31, 1991	3.496B
December 31, 1990	3.093B
December 31, 1989	2.641B
December 31, 1988	2.353B
December 31, 1987	2.082B
December 31, 1986	1.796B
December 31, 1985	1.599B
December 31, 1984	1.497B

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Annual) Range, Past 5 Years

11.60B

Minimum

2020

14.77B

Maximum

2023

13.09B

Average

12.73B

Median

2019

SG&A Expense (Annual) Benchmarks